Jeffrey Friedman
Directeur/Membre du Conseil chez DTx Pharma, Inc.
Postes actifs de Jeffrey Friedman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
DTx Pharma, Inc.
 DTx Pharma, Inc. Pharmaceuticals: MajorHealth Technology DTx Pharma, Inc. engages in the provision of biotechnology solutions. It focuses on the utilization of fatty acids to enable the delivery of RNA therapeutics to tissues and organ systems beyond the liver. The company was founded by Arthur T. Suckow, John Grundy, and Adam Pavlicek in August 2017 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 01/04/2018 | - |
| Directeur des opérations | 01/04/2018 | - |
Historique de carrière de Jeffrey Friedman
Anciens postes connus de Jeffrey Friedman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Celsense, Inc.
 Celsense, Inc. Medical DistributorsDistribution Services Celsense, Inc. operates as a biotechnology company. It offers products that enable real-time MRI detection of inflammation and cellular therapeutics. The firm’s products include Cell Sense and V-Sense. Its products are used in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response. The company was founded by Eric T. Ahrens on July 12, 2005 and is headquartered in Pittsburgh, PA. | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Operating Officer | 1 |
Sectorielle
| Distribution Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Celsense, Inc.
Celsense, Inc. Medical DistributorsDistribution Services Celsense, Inc. operates as a biotechnology company. It offers products that enable real-time MRI detection of inflammation and cellular therapeutics. The firm’s products include Cell Sense and V-Sense. Its products are used in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response. The company was founded by Eric T. Ahrens on July 12, 2005 and is headquartered in Pittsburgh, PA. | Distribution Services |
DTx Pharma, Inc.
DTx Pharma, Inc. Pharmaceuticals: MajorHealth Technology DTx Pharma, Inc. engages in the provision of biotechnology solutions. It focuses on the utilization of fatty acids to enable the delivery of RNA therapeutics to tissues and organ systems beyond the liver. The company was founded by Arthur T. Suckow, John Grundy, and Adam Pavlicek in August 2017 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Jeffrey Friedman
- Expérience
